287 related articles for article (PubMed ID: 24956378)
1. Androgen receptor enhances kidney stone-CaOx crystal formation via modulation of oxalate biosynthesis & oxidative stress.
Liang L; Li L; Tian J; Lee SO; Dang Q; Huang CK; Yeh S; Erturk E; Bushinsky D; Chang LS; He D; Chang C
Mol Endocrinol; 2014 Aug; 28(8):1291-303. PubMed ID: 24956378
[TBL] [Abstract][Full Text] [Related]
2. The Protective Roles of Estrogen Receptor
Zhu W; Zhao Z; Chou FJ; Zuo L; Liu T; Bushinsky D; Chang C; Zeng G; Yeh S
Oxid Med Cell Longev; 2019; 2019():5305014. PubMed ID: 31178964
[TBL] [Abstract][Full Text] [Related]
3. Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals.
Zhu W; Zhao Z; Chou F; Zuo L; Liu T; Yeh S; Bushinsky D; Zeng G; Chang C
Cell Death Dis; 2019 Mar; 10(4):275. PubMed ID: 30894518
[TBL] [Abstract][Full Text] [Related]
4. Kaempferol alleviates calcium oxalate crystal-induced renal injury and crystal deposition via regulation of the AR/NOX2 signaling pathway.
Yuan P; Sun X; Liu X; Hutterer G; Pummer K; Hager B; Ye Z; Chen Z
Phytomedicine; 2021 Jun; 86():153555. PubMed ID: 33852977
[TBL] [Abstract][Full Text] [Related]
5. Autophagy inhibition attenuates hyperoxaluria-induced renal tubular oxidative injury and calcium oxalate crystal depositions in the rat kidney.
Duan X; Kong Z; Mai X; Lan Y; Liu Y; Yang Z; Zhao Z; Deng T; Zeng T; Cai C; Li S; Zhong W; Wu W; Zeng G
Redox Biol; 2018 Jun; 16():414-425. PubMed ID: 29653411
[TBL] [Abstract][Full Text] [Related]
6. Curcumin ameliorates glyoxylate-induced calcium oxalate deposition and renal injuries in mice.
Li Y; Zhang J; Liu H; Yuan J; Yin Y; Wang T; Cheng B; Sun S; Guo Z
Phytomedicine; 2019 Aug; 61():152861. PubMed ID: 31029908
[TBL] [Abstract][Full Text] [Related]
7. Autophagy-endoplasmic reticulum stress inhibition mechanism of superoxide dismutase in the formation of calcium oxalate kidney stones.
Kang J; Sun Y; Deng Y; Liu Q; Li D; Liu Y; Guan X; Tao Z; Wang X
Biomed Pharmacother; 2020 Jan; 121():109649. PubMed ID: 31733571
[TBL] [Abstract][Full Text] [Related]
8. Short Chain Fatty Acids Prevent Glyoxylate-Induced Calcium Oxalate Stones by GPR43-Dependent Immunomodulatory Mechanism.
Jin X; Jian Z; Chen X; Ma Y; Ma H; Liu Y; Gong L; Xiang L; Zhu S; Shu X; Qi S; Li H; Wang K
Front Immunol; 2021; 12():729382. PubMed ID: 34675921
[TBL] [Abstract][Full Text] [Related]
9.
An L; Wu W; Li S; Lai Y; Chen D; He Z; Chang Z; Xu P; Huang Y; Lei M; Jiang Z; Zeng T; Sun X; Sun X; Duan X; Wu W
Oxid Med Cell Longev; 2021; 2021():9949697. PubMed ID: 34336124
[No Abstract] [Full Text] [Related]
10. Gallic acid ameliorates calcium oxalate crystal-induced renal injury via upregulation of Nrf2/HO-1 in the mouse model of stone formation.
Zhou D; Wu Y; Yan H; Shen T; Li S; Gong J; Li G; Mai H; Wang D; Tan X
Phytomedicine; 2022 Nov; 106():154429. PubMed ID: 36099652
[TBL] [Abstract][Full Text] [Related]
11. Theaflavin protects against oxalate calcium-induced kidney oxidative stress injury via upregulation of SIRT1.
Ye T; Yang X; Liu H; Lv P; Lu H; Jiang K; Peng E; Ye Z; Chen Z; Tang K
Int J Biol Sci; 2021; 17(4):1050-1060. PubMed ID: 33867828
[TBL] [Abstract][Full Text] [Related]
12. Metformin ameliorates calcium oxalate crystallization and stone formation by activating the Nrf2/HO-1 signaling pathway: Two birds with one stone.
Zhang X; Liang F; Li T; Jiang Y; Ren F
Arch Biochem Biophys; 2023 May; 739():109568. PubMed ID: 36914110
[TBL] [Abstract][Full Text] [Related]
13. Mucin 4 Gene Silencing Reduces Oxidative Stress and Calcium Oxalate Crystal Formation in Renal Tubular Epithelial Cells Through the Extracellular Signal-Regulated Kinase Signaling Pathway in Nephrolithiasis Rat Model.
Sun L; Zou LX; Wang J; Chen T; Han YC; Zhu DD; Zhuo SC
Kidney Blood Press Res; 2018; 43(3):820-835. PubMed ID: 29843125
[TBL] [Abstract][Full Text] [Related]
14. Identification of Resolvin D1 and Protectin D1 as Potential Therapeutic Agents for Treating Kidney Stones.
Wang B; Wei J; Huangfu Q; Gao F; Qin L; Zhong J; Wen J; Ye Z; Yang X; Liu H
Oxid Med Cell Longev; 2022; 2022():4345037. PubMed ID: 35251472
[TBL] [Abstract][Full Text] [Related]
15. Klotho inhibits the formation of calcium oxalate stones by regulating the Keap1-Nrf2-ARE signaling pathway.
Ahmatjan B; Ruotian L; Rahman A; Bin M; Heng D; Yi H; Tao C; le G; Mahmut M
Int Urol Nephrol; 2023 Feb; 55(2):263-276. PubMed ID: 36336747
[TBL] [Abstract][Full Text] [Related]
16. The Rise in Tubular pH during Hypercalciuria Exacerbates Calcium Stone Formation.
Gombedza FC; Shin S; Sadiua J; Stackhouse GB; Bandyopadhyay BC
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732005
[TBL] [Abstract][Full Text] [Related]
17. CCR2 antagonist attenuates calcium oxalate-induced kidney oxidative stress and inflammation by regulating macrophage activation.
Wang X; Xie L; Liu C
Exp Anim; 2024 May; 73(2):211-222. PubMed ID: 38199255
[TBL] [Abstract][Full Text] [Related]
18. Losartan Ameliorates Calcium Oxalate-Induced Elevation of Stone-Related Proteins in Renal Tubular Cells by Inhibiting NADPH Oxidase and Oxidative Stress.
Qin B; Wang Q; Lu Y; Li C; Hu H; Zhang J; Wang Y; Zhu J; Zhu Y; Xun Y; Wang S
Oxid Med Cell Longev; 2018; 2018():1271864. PubMed ID: 29849862
[TBL] [Abstract][Full Text] [Related]
19. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
Govindaraj A; Selvam R
BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
[TBL] [Abstract][Full Text] [Related]
20. Macrophage Function in Calcium Oxalate Kidney Stone Formation: A Systematic Review of Literature.
Taguchi K; Okada A; Unno R; Hamamoto S; Yasui T
Front Immunol; 2021; 12():673690. PubMed ID: 34108970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
